Stock Groups

3 Pharmaceutical Stocks Under $10 to Buy in September By StockNews


© Reuters. 3 Pharmaceutical Stocks Under $10 to Buy in September

The pharmaceutical industry’s increased focus on developing better treatments for many of today’s most complex diseases should help it to grow for the foreseeable future. High-priced pharma stocks could face market volatility, so we recommend investing in high quality stocks like Kamada, Catalyst Pharmaceuticals, and Kamada (NASDAQ). These stocks are trading at very affordable prices. Let’s discuss.According to ReportLinker, the global pharmaceutical contract development and manufacturing market size is expected to grow at an 8.6% CAGR to $162.69 billion by 2026. The stock market will remain volatile due to concerns about the effect of increasing COVID-19 cases and economic recovery. However, high-priced pharma stocks could see a decline in near future.

So, we think it could be wise to bet now on fundamentally sound stocks Amneal Pharmaceuticals, Inc. (AMRX), Catalyst Pharmaceuticals, Inc. (CPRX), and Kamada Ltd . (KMDA), are trading below $10.

Click here to checkout our Healthcare Sector Report for 2021

Continue reading on StockNews

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs are stocks, indexes or futures. The prices for Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, prices could be incorrect and differ from market prices. Therefore, prices on this website are only indicative and are not suitable to trade. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.